Athira Pharma, Inc.ATHANASDAQ
LOADING
|||
Net Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
5.10%
↑ 131% above average
Average (26q)
-16.24%
Historical baseline
Range
High:47.80%
Low:-324.50%
Volatility
-2292.6%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 5.10% |
| Q2 2025 | 23.81% |
| Q1 2025 | 39.06% |
| Q4 2024 | 47.80% |
| Q3 2024 | -7.01% |
| Q2 2024 | -1.98% |
| Q1 2024 | 3.47% |
| Q4 2023 | 17.24% |
| Q3 2023 | -11.40% |
| Q2 2023 | -6.39% |
| Q1 2023 | 7.68% |
| Q4 2022 | -49.26% |
| Q3 2022 | 17.04% |
| Q2 2022 | -15.99% |
| Q1 2022 | -28.40% |
| Q4 2021 | -4.24% |
| Q3 2021 | -12.17% |
| Q2 2021 | -57.61% |
| Q1 2021 | -15.11% |
| Q4 2020 | 8.92% |
| Q3 2020 | -324.50% |
| Q2 2020 | -10.36% |
| Q1 2020 | -85.32% |
| Q4 2019 | 36.34% |
| Q3 2019 | -15.17% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |